These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8104684

  • 21. Perfluorodecanoic acid, a peroxisome proliferator, activates phospholipase C, inhibits CTP:phosphocholine cytidylyltransferase, and elevates diacylglycerol in rat liver.
    Reo NV, Narayanan L, Kling KB, Adinehzadeh M.
    Toxicol Lett; 1996 Jul; 86(1):1-11. PubMed ID: 8685914
    [Abstract] [Full Text] [Related]

  • 22. Effect of the peroxisome proliferator perfluoro-n-decanoic acid on glucose transport in the isolated perfused rat liver.
    Goecke-Flora CM, Wyman JF, Jarnot BM, Reo NV.
    Chem Res Toxicol; 1995 Jul; 8(1):77-81. PubMed ID: 7703370
    [Abstract] [Full Text] [Related]

  • 23. Characterization of the promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the female rat.
    Dragan YP, Xu XH, Goldsworthy TL, Campbell HA, Maronpot RR, Pitot HC.
    Carcinogenesis; 1992 Aug; 13(8):1389-95. PubMed ID: 1354083
    [Abstract] [Full Text] [Related]

  • 24. The biochemical toxicity of perfluorodecanoic acid in the mouse is different from that of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Brewster DW, Birnbaum LS.
    Toxicol Appl Pharmacol; 1989 Jul; 99(3):544-54. PubMed ID: 2749739
    [Abstract] [Full Text] [Related]

  • 25. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver.
    Sterchele PF, Sun H, Peterson RE, Vanden Heuvel JP.
    Arch Biochem Biophys; 1996 Feb 15; 326(2):281-9. PubMed ID: 8611035
    [Abstract] [Full Text] [Related]

  • 26. Peroxisome proliferator perfluorodecanoic acid alters glutathione and related enzymes.
    Chen LC, Tatum V, Glauert HP, Chow CK.
    J Biochem Mol Toxicol; 2001 Feb 15; 15(2):107-13. PubMed ID: 11284052
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of perfluorodecanoic acid on thyroid status in rats.
    Van Rafelghem MJ, Inhorn SL, Peterson RE.
    Toxicol Appl Pharmacol; 1987 Mar 15; 87(3):430-9. PubMed ID: 3564018
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator.
    Rao MS, Lalwani ND, Watanabe TK, Reddy JK.
    Cancer Res; 1984 Mar 15; 44(3):1072-6. PubMed ID: 6692393
    [Abstract] [Full Text] [Related]

  • 32. Pathological and hepatic ultrastructural effects of a single dose of perfluoro-n-decanoic acid in the rat, hamster, mouse, and guinea pig.
    Van Rafelghem MJ, Mattie DR, Bruner RH, Andersen ME.
    Fundam Appl Toxicol; 1987 Oct 15; 9(3):522-40. PubMed ID: 3692011
    [Abstract] [Full Text] [Related]

  • 33. Regulation of hepatic malic enzyme by perfluorodecanoic acid.
    Kelling CK, Van Rafelghem MJ, Drake RL, Menahan LA, Peterson RE.
    J Biochem Toxicol; 1986 Sep 15; 1(3):23-37. PubMed ID: 3271879
    [Abstract] [Full Text] [Related]

  • 34. Effects of the peroxisome proliferator perfluoro-n-decanoic acid on hepatic gluconeogenesis and glycogenesis: a 13C NMR investigation.
    Goecke CM, Jarnot BM, Reo NV.
    Chem Res Toxicol; 1994 Sep 15; 7(1):15-22. PubMed ID: 8155820
    [Abstract] [Full Text] [Related]

  • 35. Short-term exposure to the peroxisome proliferators, perfluorooctanoic acid and perfluorodecanoic acid, causes significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats.
    Takagi A, Sai K, Umemura T, Hasegawa R, Kurokawa Y.
    Cancer Lett; 1991 Apr 15; 57(1):55-60. PubMed ID: 2025879
    [Abstract] [Full Text] [Related]

  • 36. Effect of phenobarbital and the peroxisome proliferator ciprofibrate on gamma-Glutamyltranspeptidase activity and leukotriene C4 concentration in cultured rat hepatocytes.
    Hong JT, Wilson MW, Glauert HP.
    J Biochem Toxicol; 1995 Oct 15; 10(5):239-243. PubMed ID: 8847705
    [Abstract] [Full Text] [Related]

  • 37. Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid.
    Maher JM, Aleksunes LM, Dieter MZ, Tanaka Y, Peters JM, Manautou JE, Klaassen CD.
    Toxicol Sci; 2008 Dec 15; 106(2):319-28. PubMed ID: 18757529
    [Abstract] [Full Text] [Related]

  • 38. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.
    Pitot HC, Goldsworthy TL, Moran S, Kennan W, Glauert HP, Maronpot RR, Campbell HA.
    Carcinogenesis; 1987 Oct 15; 8(10):1491-9. PubMed ID: 2888545
    [Abstract] [Full Text] [Related]

  • 39. Effects of the peroxisome proliferator di(2-ethylhexyl)phthalate on enzymes in rat liver and on carcinogen-induced liver altered foci in comparison to the promoter phenobarbital.
    Maruyama H, Tanaka T, Williams GM.
    Toxicol Pathol; 1990 Oct 15; 18(2):257-67. PubMed ID: 1975953
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of the promotion potential of chlorotrifluoroethylene trimer acid in male Sprague-Dawley rats.
    Godin CS, Flemming CD, Drerup JM, Wall HG.
    Toxicol Lett; 1993 Jan 15; 66(1):63-72. PubMed ID: 8093986
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.